Vivos Inc. (RDGL)
USD 0.1
(-11.97%)
USD 0.1
(-11.97%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 245 Thousand USD | 199.91% |
| 2022 | 81.69 Thousand USD | -51.06% |
| 2021 | 166.91 Thousand USD | -81.57% |
| 2020 | 905.5 Thousand USD | -40.57% |
| 2019 | 1.52 Million USD | 58.93% |
| 2018 | 958.66 Thousand USD | -77.59% |
| 2017 | 4.27 Million USD | -75.14% |
| 2016 | 17.2 Million USD | 17.97% |
| 2015 | 14.58 Million USD | -27.98% |
| 2014 | 20.25 Million USD | 120.91% |
| 2013 | 9.16 Million USD | -16.84% |
| 2012 | 11.02 Million USD | 85.19% |
| 2011 | 5.95 Million USD | 6.14% |
| 2010 | 5.6 Million USD | 28.69% |
| 2009 | 4.35 Million USD | -33.48% |
| 2008 | 6.55 Million USD | 52.75% |
| 2007 | 4.28 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 166.56 Thousand USD | 122.78% |
| 2024 Q1 | 74.76 Thousand USD | -69.48% |
| 2023 Q3 | 107.36 Thousand USD | -4.82% |
| 2023 Q2 | 112.81 Thousand USD | 130.28% |
| 2023 Q1 | 48.98 Thousand USD | -40.03% |
| 2023 Q4 | 245 Thousand USD | 128.19% |
| 2023 FY | 245 Thousand USD | 199.91% |
| 2022 Q2 | 215.09 Thousand USD | 151.53% |
| 2022 FY | 81.69 Thousand USD | -51.06% |
| 2022 Q3 | 160.95 Thousand USD | -25.17% |
| 2022 Q1 | 85.51 Thousand USD | -48.77% |
| 2022 Q4 | 81.69 Thousand USD | -49.24% |
| 2021 FY | 166.91 Thousand USD | -81.57% |
| 2021 Q1 | 687.29 Thousand USD | -24.1% |
| 2021 Q4 | 166.91 Thousand USD | -73.05% |
| 2021 Q3 | 619.39 Thousand USD | 2.0% |
| 2021 Q2 | 607.23 Thousand USD | -11.65% |
| 2020 Q3 | 928.13 Thousand USD | -14.39% |
| 2020 FY | 905.5 Thousand USD | -40.57% |
| 2020 Q1 | 1.26 Million USD | -17.12% |
| 2020 Q2 | 1.08 Million USD | -14.13% |
| 2020 Q4 | 905.5 Thousand USD | -2.44% |
| 2019 FY | 1.52 Million USD | 58.93% |
| 2019 Q4 | 1.52 Million USD | 9.59% |
| 2019 Q3 | 1.39 Million USD | 8.62% |
| 2019 Q2 | 1.27 Million USD | 16.0% |
| 2019 Q1 | 1.1 Million USD | 15.09% |
| 2018 Q3 | 34.7 Million USD | 225.09% |
| 2018 Q2 | 10.67 Million USD | 109.84% |
| 2018 Q1 | 5.08 Million USD | 18.93% |
| 2018 FY | 958.66 Thousand USD | -77.59% |
| 2018 Q4 | 958.66 Thousand USD | -97.24% |
| 2017 Q1 | 14.97 Million USD | -12.99% |
| 2017 FY | 4.27 Million USD | -75.14% |
| 2017 Q4 | 4.27 Million USD | 19.74% |
| 2017 Q3 | 3.57 Million USD | -76.98% |
| 2017 Q2 | 15.51 Million USD | 3.65% |
| 2016 Q2 | 22.87 Million USD | 14.35% |
| 2016 Q3 | 22.01 Million USD | -3.73% |
| 2016 FY | 17.2 Million USD | 17.97% |
| 2016 Q1 | 20 Million USD | 37.13% |
| 2016 Q4 | 17.2 Million USD | -21.86% |
| 2015 Q2 | 15.67 Million USD | -26.22% |
| 2015 FY | 14.58 Million USD | -27.98% |
| 2015 Q4 | 14.58 Million USD | 64.69% |
| 2015 Q3 | 8.85 Million USD | -43.51% |
| 2015 Q1 | 21.25 Million USD | 4.94% |
| 2014 FY | 20.25 Million USD | 120.91% |
| 2014 Q1 | 9.64 Million USD | 5.16% |
| 2014 Q4 | 20.25 Million USD | 111.13% |
| 2014 Q3 | 9.59 Million USD | -3.91% |
| 2014 Q2 | 9.98 Million USD | 3.55% |
| 2013 Q1 | 9.04 Million USD | -17.99% |
| 2013 Q2 | 8.52 Million USD | -5.68% |
| 2013 Q3 | 9 Million USD | 5.62% |
| 2013 Q4 | 9.16 Million USD | 1.79% |
| 2013 FY | 9.16 Million USD | -16.84% |
| 2012 Q2 | 7.08 Million USD | 10.02% |
| 2012 FY | 11.02 Million USD | 85.19% |
| 2012 Q4 | 11.02 Million USD | 64.54% |
| 2012 Q3 | 6.69 Million USD | -5.41% |
| 2012 Q1 | 6.43 Million USD | 8.15% |
| 2011 Q3 | 5.41 Million USD | 0.58% |
| 2011 Q2 | 5.37 Million USD | 6.69% |
| 2011 FY | 5.95 Million USD | 6.14% |
| 2011 Q4 | 5.95 Million USD | 10.0% |
| 2011 Q1 | 5.04 Million USD | -10.09% |
| 2010 FY | 5.6 Million USD | 28.69% |
| 2010 Q4 | 5.6 Million USD | -0.42% |
| 2010 Q3 | 5.63 Million USD | 9.93% |
| 2010 Q2 | 5.12 Million USD | 7.2% |
| 2010 Q1 | 4.77 Million USD | 9.66% |
| 2009 Q1 | 3.28 Million USD | -49.9% |
| 2009 Q4 | 4.35 Million USD | 9.86% |
| 2009 Q3 | 3.96 Million USD | 10.33% |
| 2009 Q2 | 3.59 Million USD | 9.54% |
| 2009 FY | 4.35 Million USD | -33.48% |
| 2008 FY | 6.55 Million USD | 52.75% |
| 2008 Q4 | 6.55 Million USD | 0.0% |
| 2007 FY | 4.28 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | 97.887% |
| BioElectronics Corporation | 16.62 Million USD | 98.526% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | 61.356% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | 63.843% |
| Polarean Imaging plc | 2.58 Million USD | 90.506% |
| AVITA Medical, Inc. | 19.86 Million USD | 98.767% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | 88.432% |
| Össur hf. | 688.8 Million USD | 99.964% |
| Zecotek Photonics Inc. | 5.86 Million USD | 95.825% |
| QHSLab, Inc. | 2.05 Million USD | 88.09% |
| Wellstar International, Inc. | 55.99 Million USD | 99.562% |
| Össur hf. | 688.8 Million USD | 99.964% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 98.476% |
| Escalon Medical Corp. | 2.94 Million USD | 91.69% |
| Aurora Spine Corporation | 6.65 Million USD | 96.318% |
| BrainsWay Ltd. | 15.31 Million USD | 98.4% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | 95.925% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 99.466% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.99% |
| Kelyniam Global, Inc. | 1.01 Million USD | 75.812% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | 11.106% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | 89.999% |
| Nanomix Corporation | 14.81 Million USD | 98.346% |
| Theraclion SA | 13.01 Million EUR | 98.118% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | 95.219% |
| Positron Corporation | 2.02 Million USD | 87.907% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | 93.234% |
| Lombard Medical, Inc. | 53.79 Million USD | 99.545% |
| ALR Technologies Inc. | 24.5 Million USD | 99.0% |
| Stratec SE | 271.97 Million USD | 99.91% |
| Vycor Medical, Inc. | 4.31 Million USD | 94.326% |
| Heart Tronics, Inc. | 1.09 Million USD | 77.621% |
| Nu-Med Plus, Inc. | 2.35 Million USD | 89.613% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | 95.526% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 99.626% |
| VMS Rehab Systems, Inc. | 201.36 USD | -121574.613% |
| Guided Therapeutics, Inc. | 5.47 Million USD | 95.525% |
| Ingen Technologies, Inc. | 5.7 Million USD | 95.709% |
| Odyssey Group International, Inc. | 6.61 Million USD | 96.294% |
| United American Healthcare Corporation | 119 Thousand USD | -105.886% |
| ECGI Holdings, Inc. | 11.94 Million USD | 97.948% |
| Capital Group Holdings, Inc. | 1.32 Million USD | 81.495% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | 83.06% |
| Urologix, Inc. | 12.64 Million USD | 98.062% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | 95.46% |
| Nexeon MedSystems Inc. | 8.48 Million USD | 97.112% |
| SS Innovations International, Inc. | 11.18 Million USD | 97.809% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | 53.367% |
| Smith & Nephew plc | 4.76 Billion USD | 99.995% |
| NIOX Group Plc | 9.8 Million USD | 97.5% |
| Fuse Medical, Inc. | 15.11 Million USD | 98.379% |
| Broncus Holding Corporation | 10.43 Million USD | 97.651% |
| Brain Scientific Inc. | 7.42 Million USD | 96.701% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 99.275% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | 69.146% |